Executive Profile

David D. Ho M.D. Chief Executive Officer and Director, Aaron Diamond AIDS Research Center

Age	Total Calculated Compensation	This person is connected to 6 Board Members in 6 different organizations across 7 different industries. See Board Relationships
--	--

Background

Dr. David D. Ho M.D. serves as the Scientific Director and Chief Executive Officer of Aaron Diamond AIDS Research Center. Dr. Ho is a Scientific Co-Founder of VivoQuest. Dr. Ho serves as an Advisor at WI Harper Group, specializing in investments in life sciences. He has been Chairman of HIV Scientific Advisory Board at Ardea Biosciences, Inc. since February 2008. He serves as a Board Member of Massachusetts Institute of Technology Corporation. He serves as a Director ... at of Aaron. He serves as a Member of Scientific Advisory Board at ImQuest Pharmaceuticals, Inc. and Optimer Pharmaceuticals, Inc. He serves as a Member of Scientific Advisory Board of Monogram Biosciences Inc., (formerly, Virologic Inc.). He served as a Member of Clinical Advisory Board at Achillion Pharmaceuticals, Inc. He served as a Member of Scientific Advisory Board at Valeant Pharmaceuticals International since April 5, 2004. Dr. Ho served as a Member of Scientific Advisory Board at XTL Biopharmaceuticals Ltd., since September 21, 2005. Dr. Ho is a Member of the American Academy of Arts and Sciences, Academia Sinica (Republic of China), Chinese Academy of Engineering, and the Institute of Medicine, National Academy of Science. Dr. Ho was a Member of the Board of Overseers of Harvard University and Member of the Board of Trustees of the California Institute of Technology. Dr. Ho is the Irene Diamond Professor of The Rockefeller University. Dr. Ho is also an honorary professor at Peking Union Medical College, Chinese Academy of Medical Sciences, Chinese Academy of Sciences, University of Hong Kong, Wuhan University, and Fudan University. Having dedicated the past 27 years actively engaged in AIDS research, he has published over 350 papers on the subject. He is one of the world's foremost experts in the treatment of viral diseases. Dr. Ho is world-renowned for his pioneering studies on the dynamics of HIV infection and its effects upon the human immune system, and is an expert on antiviral drug therapy for HIV. He was recently inducted into the California Hall of Fame. Dr. Ho has received numerous honors and awards for his scientific accomplishments. He is the recipient of six honorary doctorates (including from Swarthmore, Tufts, and Columbia) and has been chosen as the Commencement Speaker at Caltech, MIT, and Harvard School of Public Health. Additional accolades include the Presidential Medal in 2001, Time Magazine's Man of the Year in 1996 for his ground-breaking work in antiviral research, the Ernst Jung Prize in Medicine, Mayor's Award for Excellence in Science & Technology, the Squibb Award, and the Hoechst Marion Roussel Award. Dr. Ho received his degree from California Institute of Technology in 1974 and his MD from Harvard Medical School in 1978. He completed his Postdoctoral training at Massachusetts General Hospital and Harvard Medical School.

Corporate Headquarters 455 First Avenue New York, New York 10016 United States Phone: 212-448-5000 Fax: 212-725-1126 Board Members Memberships Chief Executive Officer and Director Aaron Diamond AIDS Research Center Education Bachelor's Degree 1974 California Institute of Technology Post-Doctoral Training Harvard Medical School MD 1978 Harvard Medical School Post-Doctoral Training Massachusetts General Hospital, Education Centre Other Affiliations WI Harper Group Monogram Biosciences, Inc. XTL Biopharmaceuticals Ltd. Valeant Pharmaceuticals International Achillion Pharmaceuticals, Inc. Massachusetts General Hospital Inc. Optimer Pharmaceuticals, Inc. California Institute of Technology Harvard Medical School ImQuest Pharmaceuticals, Inc University of California, Los Angeles, School of Medicine Ardea Biosciences, Inc. Massachusetts General Hospital, Education Centre

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.